Advertisement
Screener

AirSculpt Technologies, Inc. (AIRS) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Airsculpt Technologies, Inc. Return Tang Equity

Return on tangible equity is the profit a company earns on the physical and financial capital its shareholders own, leaving out goodwill and other intangible assets, shown as a percentage. It is net income divided by tangible equity, which is shareholder equity minus goodwill and intangibles; the table shows both amounts. Because acquired goodwill is removed, it runs higher than ROE for companies that grew by acquisition, and it has no meaning when goodwill exceeds equity. Goodwill and intangibles are taken at the latest reported date on or before each equity date. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Airsculpt Technologies, Inc. return tang equity for the quarter ending 2026-06-30 was 103.29%, a 123.49% increase year-over-year.
  • Airsculpt Technologies, Inc. return tang equity for the quarter ending 2026-03-31 was 65.50%, a 78.00% increase year-over-year.
  • Airsculpt Technologies, Inc. return tang equity for the quarter ending 2025-12-31 was 37.80%, a 112.83% increase year-over-year.
  • Airsculpt Technologies, Inc. return tang equity for the quarter ending 2025-09-30 was 47.14%, a 162.03% increase year-over-year.
  • Airsculpt Technologies, Inc. return tang equity for fiscal 2025 was 37.80%, a 112.83% increase from fiscal 2024.
  • Airsculpt Technologies, Inc. return tang equity for fiscal 2024 was 17.76%, a 90.30% increase from fiscal 2023.
  • Airsculpt Technologies, Inc. return tang equity for fiscal 2023 was 9.33%, a 60.53% decline from fiscal 2022.
  • Airsculpt Technologies, Inc. return tang equity for fiscal 2022 was 23.65%, a change of 43.17% from fiscal 2021.
Available history
2021-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2026-06-30103.29%-$11.74M-$11.36M
2026-03-3165.50%-$11.22M-$17.12M
2025-12-3137.80%-$11.67M-$30.86M
2025-09-3047.14%-$17.75M-$37.66M
2025-06-3046.22%-$14.28M-$30.9M
2025-03-3136.80%-$16.89M-$45.91M
2024-12-3117.76%-$8.02M-$45.14M
2024-09-3017.99%-$7.55M-$41.98M
2024-06-307.81%-$3.18M-$40.69M
2024-03-31-4.16%$1.8M-$43.39M
2023-12-319.33%-$4.24M-$45.42M
2023-09-3015.74%-$7.1M-$45.08M
2023-06-3026.15%-$12.81M-$48.98M
2023-03-3124.82%-$14M-$56.42M
2022-12-3123.65%-$14.68M-$62.07M
2022-09-3012.80%-$7.88M-$61.55M
2022-06-30-19.99%$7.55M-$37.78M
2022-03-31-36.53%$17M-$46.53M
2021-12-31-44.97%$24.31M-$54.06M

Annual Return Tang Equity

DateReturn Tang EquityNet income 12 monthTangible equity
2025-12-3137.80%-$11.67M-$30.86M
2024-12-3117.76%-$8.02M-$45.14M
2023-12-319.33%-$4.24M-$45.42M
2022-12-3123.65%-$14.68M-$62.07M
2021-12-31-19.52%$10.55M-$54.06M

Similar stocks

Stock NameCountryMarket CapPE Ratio
LifeMD, Inc. (LFMD)United States$0.141B982.53
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Teladoc Health, Inc. (TDOC)United States$1.114B-8.68